Nuwellis (NUWE) EBT Margin (2013 - 2026)

Nuwellis (NUWE) reported EBT Margin of 188.97% for Q1 2026, down 3073.0% on a YoY basis from 6.36% in Q1 2025, and down 130.3% quarter-over-quarter from 623.68% in Q4 2025.

Nuwellis (NUWE) EBT Margin (2013 - 2026) Analysis & Trends

Nuwellis has reported EBT Margin for 14 years, with the latest figure at 188.97% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 3073.0% year-over-year to 188.97%; the trailing twelve-month figure through Mar 2026 stood at 17.15% (up 9523.0% YoY), and the FY2025 full-year result was 0.29%, up 12832.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 188.97%, down from 623.68% in the prior quarter.
  • The five-year high for EBT Margin was 623.68% in Q4 2025, with the low at 727.48% in Q2 2025.
  • Historically, EBT Margin has averaged 70.74% across 5 years, with a median of 187.31% in 2022.
  • Annual changes were most pronounced in 2024 — EBT Margin slumped 64173 bps — and 2025, when it surged 68815 bps.
  • Nuwellis' EBT Margin stood at 541.17% in 2022, then gained by 7 bps to 577.26% in 2023, then slumped by 111 bps to 64.47% in 2024, then soared by 1067 bps to 623.68% in 2025, then sank by 130 bps to 188.97% in 2026.
  • The last three EBT Margin figures came in at 188.97% (Q1 2026), 623.68% (Q4 2025), and 21.11% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 12.98%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 14.12%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 15.57%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 22.33%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 27.84%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 4.87%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 22.61%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 9.84%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 19.17%
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn -188.97%

Historic Data

Download Data
DateValue
Mar 31, 2026 -188.97%
Dec 31, 2025 623.68%
Sep 30, 2025 21.11%
Jun 30, 2025 -727.48%
Mar 31, 2025 -158.25%
Dec 31, 2024 -64.47%
Sep 30, 2024 99.62%
Jun 30, 2024 -352.01%
Mar 31, 2024 -233.06%
Dec 31, 2023 577.26%
Sep 30, 2023 -139.64%
Jun 30, 2023 -233.40%
Mar 31, 2023 -355.04%
Dec 31, 2022 541.17%
Sep 30, 2022 -187.31%
Jun 30, 2022 -193.58%
Mar 31, 2022 -232.14%
Dec 31, 2021 928.99%
Sep 30, 2021 -284.40%
Jun 30, 2021 -188.52%